1) Bautista-Quach M. A, Ake C. D, Chen M, and Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol 2012;3(3):209-225
2) Ghimire P, Wu G, and Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol 2011 February 14; 17(6): 697-707
3) Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer 1980;46(1):215-222.
4) Koniaris LG, Drugas G, Katzman PJ, Salloum R. Management of gastrointestinal lymphoma. Journal of the American College of Surgeons. 2003;197(1):127-41.
5) Andriani A, Zullo A, Di Raimondo F, Patti C, Tedeschi L, Recine U, et al. Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Aliment Pharmacol Ther. 2006;23(6):721-6.
6) Zullo A, Hassan C, Andriani A, Cristofari F, Cardinale V, Spinelli GP, et al. Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol. 2010;44(5):340-4.
7) Zukerberg LR, Ferry JA, Southern JF, Harris NL. Lymphoid infiltrates of the stomach. Evaluation of histologic criteria for the diagnosis of low-grade gastric lymphoma on endoscopic biopsy specimens. Am J Surg Pathol. 1990;14(12):1087-99.
8) Vetro C, Romano A, Amico I, Conticello C, Motta G, Figuera A, et al. Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up. World J Gastroenterol. 2014;20(36):12993-3005.
9) Olszewska-Szopa M, and Wróbel T. Gastrointestinal non-Hodgkin lymphomas. Adv Clin Exp Med. 2019;28(8):1119–1124
10) Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H. WHO classification of tumours of haematopoietic and lymphoid tissues-Revised 4th edition. World Health Organization Classification of Tumours. 2017.
11) Hanafy A.K, Morani A.C, Menias C.O, and et al. Hematologic malignancies of the gastrointestinal luminal tract. Abdominal Radiology (2020) 45:3007–3027
12) Pizzi M, Sabattini E, Parente P and et al. Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach. Pathologica. 2020 Sep; 112(3): 227–247.
13) Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangel CS, et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood. 1988;71(4):1157-60.
14) Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-82.
15) Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol. 2011;29(2):200-7.
16) Gualco G, Bacchi LM, Domeny-Duarte P, Natkunam Y, Bacchi CE. The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma. Mod Pathol. 2012;25(11):1439-45.
17) Hu S, Xu-Monette ZY, Balasubramanyam A, Manyam GC, Visco C, Tzankov A, et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013;121(14):2715-24.
18) Swerdlow SH. Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC. Hematology Am Soc Hematol Educ Program. 2014;2014(1):90-9.
19) Thomas A.S, Schwartz M, and Quigley E. Gastrointestinal lymphoma: the new mimic. Shirwaikar Thomas A, et al. BMJ Open Gastro 2019;6:e000320.
20) Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2005;23(26):6370-8.
21) Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. Journal of gastrointestinal oncology. 2012;3(3):209-25.
22) Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, et al. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. 2012;43(9):1436-43.
23) Jain P, and Wnag M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019; 94:710–725.
24) Nguyen V, Nguyen B, Petris GD, Nguyen C. Education and imaging. Gastrointestinal: gastrointestinal involvement of mantle cell lymphoma. J Gastroenterol Hepatol. 2012;27(3):617.
25) Salar A, Juanpere N, Bellosillo B, Domingo-Domenech E, Espinet B, Seoane A, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol. 2006;30(10):1274-80.
26) Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94(11):1555-62.
27) Misdraji J, Harris NL, Hasserjian RP, Lauwers GY, Ferry JA. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol. 2011;35(9):1255-63.
28) Leich E, Salaverria I, Bea S, Zettl A, Wright G, Moreno V, et al. Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. Blood. 2009;114(4):826-34.
29) Takata K, Sato Y, Nakamura N, Tokunaka M, Miki Y, Yukie Kikuti Y, et al. Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics. Mod Pathol. 2013;26(1):22-31.
30) Jacobson C and LaCasce A. How I treat Burkitt lymphoma in adults. Blood (2014) 124 (19): 2913–2920.
31) Choi SY, Kim SJ, Kim WS, Kim K, Ko YH. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis. Virchows Arch. 2011;459(5):495-502.
32) Haralambieva E, Boerma EJ, van Imhoff GW, Rosati S, Schuuring E, Müller-Hermelink HK, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29(8):1086-94.